{"database": "lobbying", "table": "lobbying_activities", "rows": [[988140, "b5f81920-cd21-4c29-a761-a1927fc1c75a", "Q3", "CHAMBER HILL STRATEGIES", 400645947, "BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC.", 2010, "third_quarter", "MMM", "Implementation issues affecting biopharmaceutical manufacturers related to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act of 2010", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2010-10-06T12:12:48.830000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["988140"], "units": {}, "query_ms": 112.92296997271478, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}